Etubics

About:

Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.

Website: http://etubics.com

Top Investors: National Institutes of Health

Description:

Etubics Corporation is a Seattle based biopharmaceutical company developing targeted immunotherapies and vaccine products for a wide range of resilient diseases. Etubics patent-protected technology has been proven to be safer, more efficient and more effective than current vectored vaccines and gene delivery platforms.